China Biologics Market: Opportunities in Oncology and Autoimmune Treatments
The China Biologics Market has seen exponential growth in oncology and autoimmune therapeutics, driven by increasing disease prevalence and evolving patient needs. Biologics, including monoclonal antibodies, fusion proteins, and cell therapies, are transforming treatment approaches by targeting diseases with high specificity. Pharmaceutical companies are expanding their research pipelines and...
0 Comments 0 Shares 4 Views 0 Reviews